Quick Answer
bioAffinity Technologies, Inc. reported Total Assets of $10.96 million for the year ending 2025.
- bioAffinity Technologies, Inc. showed an increase of +68.3% in Total Assets from 2024 to 2025.
- This data is from bioAffinity Technologies, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: $14.06 million | Q1 2023: $10.46 million | Q2 2023: $8.87 million | Q3 2023: $10.19 million | Q1 2024: $8.05 million | Q2 2024: $6.66 million | Q3 2024: $6.55 million | Q1 2025: $5.55 million | Q2 2025: $4.75 million | Q3 2025: $11.55 million.
- Over the full 5 years of available data (2021 to 2025), bioAffinity Technologies, Inc.'s Total Assets has grown by 654.2%.
- Historical annual values: Fiscal year 2025: $10.96 million | Fiscal year 2024: $6.51 million | Fiscal year 2023: $8.22 million | Fiscal year 2022: $12.18 million | Fiscal year 2021: $1.45 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: